Literature DB >> 19324384

Sphenoid and optic nerve sheath meningioma revealed by recurrent brain infarctions.

A Mourad1, J-P Guichard, C Vignal, M-G Bousser, K Vahedi.   

Abstract

Meningioma, though benign, may invade adjacent structures such as bone, soft tissues, dural sinuses and arteries. However brain infarctions secondary to meningioma involving the cavernous sinus and encasing and narrowing the intracranial carotid artery are rare. We report the case of a young man with recurrent left carotid artery infarctions due to a left sphenoid meningioma infiltrating the posterior optic nerve sheath through the optic canal and circumscribing the intracranial carotid artery. The patient had a gradually progressive occlusion of the middle cerebral artery, the distal internal carotid artery and finally the anterior cerebral artery ipsilateral to the sphenoid meningioma.

Entities:  

Mesh:

Year:  2009        PMID: 19324384     DOI: 10.1016/j.neurol.2009.02.004

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Correlating hemodynamic magnetic resonance imaging with high-field intracranial vessel wall imaging in stroke.

Authors:  Weston Langdon; Manus J Donahue; Anja G van der Kolk; Swati Rane; Megan K Strother
Journal:  J Radiol Case Rep       Date:  2014-06-30

2.  Analyses on the misdiagnoses of 25 patients with unilateral optic nerve sheath meningioma.

Authors:  Jun-Feng Mao; Xiao-Bo Xia; Xiang-Bo Tang; Xue-Yong Zhang; Dan Wen
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

3.  Noninvasive intracranial pressure estimation by orbital subarachnoid space measurement: the Beijing Intracranial and Intraocular Pressure (iCOP) study.

Authors:  Xiaobin Xie; Xiaojun Zhang; Jidi Fu; Huaizhou Wang; Jost B Jonas; Xiaoxia Peng; Guohong Tian; Junfang Xian; Robert Ritch; Lei Li; Zefeng Kang; Shoukang Zhang; Diya Yang; Ningli Wang
Journal:  Crit Care       Date:  2013-07-24       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.